BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 106910
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106910
Table 3 Comparison of serum tumor markers (carbohydrate antigen 19-9, carcinoembryonic antigen), serum soluble intercellular adhesion molecule-1, and chitinase-3-like protein 1 Levels in patients with pancreatic cancer at different tumor-node-metastasis stages, mean ± SD
Group
n
CA-19-9 (U/mL)
CEA (U/mL)
sICAM-1 (μg/L)
CHI3 L1 (ng/mL)
Stage I pancreatic cancer2498.43 ± 6.218.62 ± 1.12213.51 ± 26.31167.92 ± 5.47
Stage II pancreatic cancer27131.37 ± 22.5812.39 ± 2.22254.82 ± 25.79192.46 ± 11.39
t-10.04510.8288.00713.870
P value-< 0.001< 0.001< 0.001< 0.001


Write to the Help Desk